Table of Content



Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Segment Definitions
1.2.1. Cancer
1.2.2. Diagnosis
1.2.3. End use
1.2.4. Regional Scope
1.2.5. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Cancer outlook
2.2.2. Diagnosis outlook
2.2.3. End use outlook
2.3. Regional outlook
2.4. Competitive Insights
Chapter 3. China Lung Cancer Screening Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. China Lung Cancer Screening Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitutes
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic landscape
3.3.2.3. Social landscape
3.3.2.4. Technological landscape
3.3.2.5. Environmental landscape
3.3.2.6. Legal landscape
Chapter 4. China Lung Cancer Screening Market: Cancer Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. China Lung Cancer Screening Market: Cancer Movement Analysis
4.3. China Lung Cancer Screening Market by Cancer Outlook (USD Million)
4.4. Market Size & Forecasts and Trend Analysis, 2018 to 2030 for the following
4.5. Non-small Cell Lung Cancer (NSCLC)
4.5.1. Non-small Cell Lung Cancer (NSCLC) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Small Cell Lung Cancer (SCLC)
4.6.1. Small Cell Lung Cancer (SCLC) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. China Lung Cancer Screening Market: Diagnosis Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. China Lung Cancer Screening Market: Diagnosis Movement Analysis
5.3. China Lung Cancer Screening Market by Diagnosis Outlook (USD Million)
5.4. Market Size & Forecasts and Trend Analysis, 2018 to 2030 for the following
5.5. Low Dose Spiral CT Scan
5.5.1. Low Dose Spiral CT Scan Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Chest X-ray
5.6.1. Chest X-ray Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. China Lung Cancer Screening Market: End Use Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. China Lung Cancer Screening Market: End Use Movement Analysis
6.3. China Lung Cancer Screening Market by End Use Outlook (USD Million)
6.4. Market Size & Forecasts and Trend Analysis, 2018 to 2030 for the following
6.5. Hospitals and Clinics
6.5.1. Hospitals and Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Diagnostic Centers
6.6.1. Diagnostic Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7. Others
6.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Market Participant Categorization
7.2. Key Company Profiles
7.2.1. Biodesix
7.2.1.1. Company overview
7.2.1.2. Financial performance
7.2.1.3. Product benchmarking
7.2.1.4. Strategic initiatives
7.2.2. DELFI Diagnostics, Inc.
7.2.2.1. Company overview
7.2.2.2. Financial performance
7.2.2.3. Product benchmarking
7.2.2.4. Strategic initiatives
7.2.3. GE HealthCare
7.2.3.1. Company overview
7.2.3.2. Financial performance
7.2.3.3. Product benchmarking
7.2.3.4. Strategic initiatives
7.2.4. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
7.2.4.1. Company overview
7.2.4.2. Financial performance
7.2.4.3. Product benchmarking
7.2.4.4. Strategic initiatives
7.2.5. Siemens Healthineers AG
7.2.5.1. Company overview
7.2.5.2. Financial performance
7.2.5.3. Product benchmarking
7.2.5.4. Strategic initiatives
7.2.6. Koninklijke Philips N.V.
7.2.6.1. Company overview
7.2.6.2. Financial performance
7.2.6.3. Product benchmarking
7.2.6.4. Strategic initiatives
7.2.7. CANON MEDICAL SYSTEMS CORPORATION
7.2.7.1. Company overview
7.2.7.2. Financial performance
7.2.7.3. Product benchmarking
7.2.7.4. Strategic initiatives
7.2.8. Medtronic
7.2.8.1. Company overview
7.2.8.2. Financial performance
7.2.8.3. Product benchmarking
7.2.8.4. Strategic initiatives
7.2.9. Shanghai United Imaging Healthcare Co., LTD
7.2.9.1. Company overview
7.2.9.2. Financial performance
7.2.9.3. Product benchmarking
7.2.9.4. Strategic initiatives
7.2.10. Freenome Holdings, Inc.
7.2.10.1. Company overview
7.2.10.2. Financial performance
7.2.10.3. Product benchmarking
7.2.10.4. Strategic initiatives



List of Figures

List of Figures

Fig. 1 Information procurement
Fig. 2 Primary research pattern
Fig. 3 Market research approaches
Fig. 4 Value chain-based sizing & forecasting
Fig. 5 Market formulation & validation
Fig. 6 China lung cancer screening market segmentation
Fig. 7 Market driver analysis (current & future impact)
Fig. 8 Market restraint analysis (current & future impact)
Fig. 9 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 10 Porter’s five forces analysis
Fig. 11 China lung cancer screening market, cancer outlook key takeaways (USD Million)
Fig. 12 China lung cancer screening market: cancer movement analysis 2023 & 2030 (USD Million)
Fig. 13 Non-small Cell Lung Cancer (NSCLC) market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 14 Small Cell Lung Cancer (SCLC) market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 15 China lung cancer screening market, diagnosis outlook key takeaways (USD Million)
Fig. 16 China lung cancer screening market: diagnosis movement analysis 2023 & 2030 (USD Million)
Fig. 17 Low dose spiral CT scan market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 18 Chest x-ray market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 19 China lung cancer screening market, end use outlook key takeaways (USD Million)
Fig. 20 China lung cancer screening market: end use movement analysis 2023 & 2030 (USD Million)
Fig. 21 Hospitals and clinics market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 22 Diagnostic centers market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 23 Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 24 List of key emerging company’s/type disruptors/innovators

List of Tables

List of Tables

Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 China lung cancer screening market, by cancer, 2018 - 2030 (USD Million)
Table 4 China lung cancer screening market, by diagnosis, 2018 - 2030 (USD Million)
Table 5 China lung cancer screening market, by end use, 2018 - 2030 (USD Million)